Mammocat advanced full field digital mammography system
Ended Project Grant Awarded Last action
- Award ID
- R44CA268305
- Recipient
-
Fischer Imaging Inc. UEI CW3TVGNJAYM6
- Awarding agency
-
National Cancer Institute
National Institutes of Health, Department of Health and Human Services
- Obligated
- $3,026,055
Award facts
- Assistance listing
- 93.394 Cancer Detection and Diagnosis Research
- Completion date
- Originally
- Place of performance
- Colorado, USA
Award details come from USAspending.gov.
Description
- Abstract
- Breast cancer remains a leading cause of cancer related death among women in the united states. Mammography, the only cost effective method approved for population screening of breast cancer, fails to find cancer in many women and causes too many unnecessary call backs on the rest. Fischer imaging has developed proprietary "slot scanning" technology that significantly improves contrast and image resolution of today's mammography and lowers the radiation dose. Our technology also removes the need for painful breast compression. These essential enhancements will improve clinical performance by finding missed cancers and reducing unnecessary treatment while increasing patient compliance with mammography recommendations. This proposal describes the development and feasibility bench testing of mammocat™ DM, our first product, which will provide superior two view mammography. This product is regulated as a class II, 510K device and current procedure reimbursement by CMS and private payors allows a facility with an average patient volume to pay off the device in about a year. A key feature of mammocat DM will be upgradeability to mammocat DBT, our second product, which will allow image capture over multiple angles to give IT digital breast tomosynthesis capability.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Amendment | $0 | |
| Amendment | $0 | |
| Amendment | $979,261 | |
| Amendment | $1,023,397 | |
| Original award | $1,023,397 |
Quick answers
Who received award R44CA268305?
R44CA268305 was awarded to Fischer Imaging Inc. by National Cancer Institute (National Institutes of Health) on March 1, 2022.
How much is award R44CA268305 worth?
$3,026,055 has been obligated on R44CA268305.
On GovTribe
See this award's full record
- Every transaction and subaward
- The recipient's other awards and teaming partners
- Similar grant awards
- Ask GovTribe AI about this award